LJUBLJANA, March 22 (Reuters) - Slovenian generic drug producer Krka made a preliminary 2017 group net profit of 152.6 million euros ($187.9 million), up 41 percent from 2016, the company said on Thursday.
It said sales rose to 1.3 billion euros from 1.2 billion a year before.
$1 = 0.8121 euros Reporting by Marja Novak Editing by Mark Potter